Clayton, Dubilier & Rice and TPG (TPG) offered to buy Covetrus (CVET) for $21 a share in cash

  • May 23, 2022

POTENTIAL DEAL DETAILS

StockCovetrus, Inc.SymbolCVET
Date Announced05/20/2022Source Bloomberg
TypeUnsolicited BidAcquiring Company/Person Clayton, Dubilier & Rice
Date of Confirmation: 05/25/2022Price at Confirmation: $19.66
Potential Profit: -0.25%Annualized Profit: -18.52%

Clayton, Dubilier & Rice, and TPG (TPG) offered to buy all of the outstanding shares of animal-health technology and services provider Covetrus Inc. (CVET) for $21 a share in cash.

Update(s):

May 25, 2022: Covetrus (CVET) announced that it has entered into a definitive agreement pursuant to which funds affiliated with Clayton, Dubilier & Rice, a global private investment firm, and TPG Capital, the private equity platform of global alternative asset management firm TPG , will acquire all outstanding shares of Covetrus common stock not already owned by affiliates of CD&R for $21.00 per share in cash, representing an enterprise value of approximately $4 billion.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.